ZBTB17 and Alzheimer disease: This finding aligns with known roles of NF‐κB in inflammation and immune responses, suggesting that NKRF and ZBTB17 influence AD and AS progression through NF‐κB pathway modulation in these cells.8, 36, 37, 38